EDGAR Filing Documents for 0001213900-21-001182

Form 8-K - Current report:

SEC Accession No. 0001213900-21-001182

Filing Date

2021-01-08

Accepted

2021-01-08 16:19:48

Documents

Period of Report

2021-01-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea132703-8k_hoththerap.htm	8-K	30236
2	FORM OF SECURITIES PURCHASE AGREEMENT	ea132703ex10-1_hoththerap.htm	EX-10.1	220212
3	FORM OF WARRANT	ea132703ex10-2_hoththerap.htm	EX-10.2	91378
4	FORM OF REGISTRATION RIGHTS AGREEMENT	ea132703ex10-3_hoththerap.htm	EX-10.3	135443
5	FORM OF PLACEMENT AGENT WARRANT	ea132703ex10-4_hoththerap.htm	EX-10.4	98108
6	PRESS RELEASE DATED JANUARY 4, 2021	ea132703ex99-1_hoththerap.htm	EX-99.1	11447
7	PRESS RELEASE DATED JANUARY 5, 2021	ea132703ex99-2_hoththerap.htm	EX-99.2	12791
8	GRAPHIC	ex99-1_001.jpg	GRAPHIC	3729
9	GRAPHIC	ex99-2_001.jpg	GRAPHIC	3589
	Complete submission text file	0001213900-21-001182.txt		611344

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020

Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261

Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)